General Range
FORLIC-1.2
Price on request/100 · MOQ 100 boxes
FORLIC-1.2 Injection by Fortune Labs contains Amoxycillin and Potassium Clavulanate, a prescription antibiotic combination formulated for treating selected bacterial infections caused by susceptible microorganisms. Amoxycillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, while Potassium Clavulanate blocks certain beta-lactamase enzymes responsible for antibiotic resistance. FORLIC-1.2 may be prescribed for selected respiratory tract, urinary tract, skin, soft tissue, bone and intra-abdominal infections when clinically appropriate. Available as a 1.2 gm sterile powder for injection in a protective carton with an accompanying diluent, the formulation is intended for intravenous administration by trained healthcare professionals. Treatment requires consideration of bacterial susceptibility, penicillin allergy, kidney function, liver health, potential adverse effects and recommended treatment duration.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Amoxycillin & Potassium Clavulanate for Injection IP
- Packaging Type
- Glass Injection Vial with Protective Cap, Accompanying Diluent and Printed Carto
- Packaging Size
- 1.2 gm per vial
- Dosage Form
- Sterile Powder for Injection
- Treatment
- May be prescribed for selected bacterial respiratory infections.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
